Comments on: Metabolic Duo 22nd Aug REPLAY – with Prof Thomas Seyfried !

By: Aidan Waine

Aidan Waine — Wed, 28 Aug 2024 16:57:35 +0000

Fascinating session, thanks!

Whatever the aetiology, Paul Jaminet’s new drug from Angiex–currently starting clinical trials–promises to target all solid tumors with unparalleled off-target low toxicity and may be a great complement to Prof Seyfried’s approach.

https://www.adcreview.com/clinical-trials-update/first-patient-dosed-in-first-in-human-trial-of-agx101-a-novel-adc-targeting-tm4sf1/

By: Claudia Wilkinson

Claudia Wilkinson — Mon, 26 Aug 2024 10:32:41 +0000

It would be really great if someone could do a DrBeen style (Dr Mobeen Syed on YouTube, great medical educator with skill at drawing out the mechanisms and excellent teacher) style series of lectures explaining his theory with diagrams from the first principles, including the experiments about transferring nuclei from cancer cells to normal cells and vice versa. This is too complicated to verbally explain to my friends with cancer. I would happily pay in the same way you pay for a book. DrBeen has, in the last few years, come around more to our way of thinking and may already have done something like this in his lecture series and Paul Marik has recently discovered the metabolic theory and mentions it in his book, Cancer Care which is mainly a compendium of useful information on repurposed drugs.
Here is a link to a Dhru Purohit podcast he did with the Hippocrates Research Foundation who are a small group of doctors who help patients interpret Thomas Seyfried’s work for their own cancers.
https://youtu.be/pm2ia_Nsfc8?si=9fmnP-tG4JMWPZjY

By: William Hare

William Hare — Fri, 23 Aug 2024 21:49:16 +0000

Excellent interview. Read Dr. Seyfried’s textbook twice when it first came out. Can you imagine if “all hands on deck” were put towards researching Metabolic cancer therapy aggressively? Thanks for doing interview. Bill